Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
Rishi R. Goel, Mark M. Painter, Kendall A. Lundgreen, et al.
Cell (2022) Vol. 185, Iss. 11, pp. 1875-1887.e8
Open Access | Times Cited: 185

Showing 1-25 of 185 citing articles:

Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure
Catherine J. Reynolds, Corinna Pade, Joseph M. Gibbons, et al.
Science (2022) Vol. 377, Iss. 6603
Open Access | Times Cited: 322
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
Frauke Muecksch, Zijun Wang, Alice Cho, et al.
Nature (2022) Vol. 607, Iss. 7917, pp. 128-134
Open Access | Times Cited: 272
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
John E. Bowen, Amin Addetia, Ha V. Dang, et al.
Science (2022) Vol. 377, Iss. 6608, pp. 890-894
Open Access | Times Cited: 174
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection
Chengzi I. Kaku, Alan Bergeron, Clas Ahlm, et al.
Science Immunology (2022) Vol. 7, Iss. 73
Open Access | Times Cited: 120
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
Wafaa B. Alsoussi, Sameer Kumar Malladi, Julian Q. Zhou, et al.
Nature (2023) Vol. 617, Iss. 7961, pp. 592-598
Open Access | Times Cited: 114
mRNA vaccines in disease prevention and treatment
Gang Zhang, Tianyu Tang, Yinfeng Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 109
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 96
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity
Muriel Aguilar-Bretones, Ron A. M. Fouchier, Marion Koopmans, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 1
Open Access | Times Cited: 86
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Mark M. Painter, Timothy S. Johnston, Kendall A. Lundgreen, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1711-1724
Open Access | Times Cited: 71
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, et al.
EBioMedicine (2023) Vol. 90, pp. 104545-104545
Open Access | Times Cited: 44
Immune imprinting and next-generation coronavirus vaccines
Chloe Qingzhou Huang, Sneha Vishwanath, George Carnell, et al.
Nature Microbiology (2023) Vol. 8, Iss. 11, pp. 1971-1985
Closed Access | Times Cited: 43
A guide to adaptive immune memory
Nora Lam, Yoon Seung Lee, Donna L. Färber
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 35
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
Hassen Kared, Asia‐Sophia Wolf, Amin Alirezaylavasani, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 60
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
Xinxue Liu, Alasdair Munro, Shuo Feng, et al.
Journal of Infection (2022) Vol. 84, Iss. 6, pp. 795-813
Open Access | Times Cited: 54
Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans
Zijun Wang, Pengcheng Zhou, Frauke Muecksch, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 12
Open Access | Times Cited: 49
Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
Deepta Bhattacharya
Immunity (2022) Vol. 55, Iss. 6, pp. 945-964
Open Access | Times Cited: 48
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses
Clarisa M. Buckner, Lela Kardava, Omar El Merhebi, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4333-4346.e14
Open Access | Times Cited: 47
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Laurent Rénia, Yun Shan Goh, Angéline Rouers, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 45
Impact of SARS-CoV-2 exposure history on the T cell and IgG response
Roanne Keeton, Marius B. Tincho, Akiko Suzuki, et al.
Cell Reports Medicine (2022) Vol. 4, Iss. 1, pp. 100898-100898
Open Access | Times Cited: 43
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines
John E. Bowen, Kaitlin R. Sprouse, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 42
Pre-existing immunity modulates responses to mRNA boosters
Tanushree Dangi, Sarah Sanchez, Min Han Lew, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112167-112167
Open Access | Times Cited: 36
Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants
Yubin Liu, Ziyi Wang, Xinyu Zhuang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2
Yves Zurbuchen, Jan Michler, Patrick Taeschler, et al.
Nature Immunology (2023) Vol. 24, Iss. 6, pp. 955-965
Open Access | Times Cited: 30
Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2
Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosus
Kavita Y. Sarin, Hong Zheng, Yashaar Chaichian, et al.
JCI Insight (2024) Vol. 9, Iss. 5
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top